Andy is one of NXD’s specialists in the Life Sciences and Chemicals sectors, with over 25 years of experience building value in businesses ranging from venture capital backed start up phase through to large listed companies. He has substantial experience in fundraising from private equity sources and has led a company to a successful AIM listing.
He has worked in sector leading international companies such as AstraZeneca, Cap Gemini and smaller companies such as Phoqus Pharmaceuticals. Achievements include: /• Raising over £12m of venture capital funding and listing on Aim at a market capitalisation of £50m for a pharmaceutical business
Turnaround of €100m European based business from loss making to profit making within 18mths
Development and implementation of market entry strategy into China for speciality chemicals manfacturing and marketing business
Andy has particular skills in strategy, business plan development, business development (both organic and M&A driven), acquisition due diligence and building and developing management teams. He is experienced in both executive or consulting/non executive roles and understands each requires a different approach to be effective and add value.
- Business Development
- Sales & Marketing
- Healthcare, Medical & Pharmaceutical
- Industrial, Chemical & Engineering
- Mining, forestry & paper